Takatsuki, Japan

Chiaki Tagawa

This inventor holds 2 USPTO granted patents. Top assignees: Hightech Receptor Ab, Sumitomo Chemical Company, Limited, Sumitomo Pharmaceuticals Company Limited. Active years: 1993-1994.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chiaki Tagawa: Innovator in Protein Engineering

Introduction

Chiaki Tagawa is a prominent inventor based in Takatsuki, Japan. She has made significant contributions to the field of protein engineering, particularly in the development of proteins that interact with immunoglobulins. With a total of 2 patents, her work has implications for various biomedical applications.

Latest Patents

Chiaki's latest patents include a gene encoding a novel protein H capable of binding to IgG. This gene, isolated from Streptococcus sp. AP1, was expressed in host cells, specifically E. coli, to produce Protein H. This protein is notable for its ability to bind specifically to human IgG of all subclasses, showcasing its potential utility in therapeutic and diagnostic applications.

Career Highlights

Throughout her career, Chiaki has worked with notable companies such as Hightech Receptor Ab and Sumitomo Pharmaceuticals Company Limited. Her expertise in protein engineering has allowed her to contribute to advancements in the field, enhancing the understanding of protein interactions.

Collaborations

Chiaki has collaborated with esteemed colleagues, including Hideyuki Gomi and Tatsunobu Hozumi. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Chiaki Tagawa's work in protein engineering exemplifies the impact of innovative research on biotechnology. Her contributions continue to influence the field, paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…